Gatifloxacin — Active Pharmaceutical Ingredient

Gatifloxacin is an active pharmaceutical ingredient found in 3 FDA-approved drug products. Forms: SOLUTION/DROPS, SOLUTION. Routes: OPHTHALMIC.

This content is for informational purposes only. Always consult a healthcare professional.

Gatifloxacin (3 brand names, 2 dosage forms, 1 route)

Available dosage forms: SOLUTION/DROPS, SOLUTION.

Routes of administration: OPHTHALMIC.

Brand Names

  • GATIFLOXACIN
  • ZYMAR
  • ZYMAXID

Indications and Usage

Gatifloxacin ophthalmic solution 0.5 % is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus mitis group* Streptococcus oralis* Streptococcus pneumoniae Aerobic gram-negative bacteria: Haemophilus influenzae *Efficacy for these organisms were studied in fewer than 10 infections.

Dosage and Administration

Day 1: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times. Day 2 through Day 7: Instill one drop two to four times daily in the affected eye(s) while awake.

Contraindications

Gatifloxacin ophthalmic solution 0.5 % is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication [see Warnings and Precautions (5.1)].

Adverse Reactions

The following serious adverse reactions are described elsewhere in the labeling: Hypersensitivity [see Contraindications (4) and Warnings and Precautions (5.1)] Growth of Resistant Organisms With Prolonged Use [see Warnings and Precautions (5.2)] Corneal Endothelial Cell Injury [see Warnings and Precautions (5.3)]

Mechanism of Action

Gatifloxacin is a quinolone antimicrobial [see Microbiology (12.4)].

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.